OUTLOOK THERAPEUTICS INC (OTLK)
US69012T3059 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 17.40M | 14.48M | 12.54M | |||
| Cash Equivalents | 10.36M | 23.39M | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 10.03M | 7.59M | 10.12M | 7.03M | 5.41M | |||
| Total Current Assets | 20.39M | 30.98M | 27.52M | 21.51M | 17.94M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.96K | 26.17K | 70.00K | 280.00K | 490.00K | |||
| Investments And Advances | 796.48K | 793.93K | 800.00K | 850.00K | 900.00K | |||
| Other Non-Current Assets | 484.32K | 501.30K | 130.00K | 170.00K | 390.00K | |||
| Total Non-Current Assets | 1.30M | 1.32M | 1.01M | 1.30M | 1.79M | |||
| TOTAL ASSETS | 21.68M | 32.30M | 28.53M | 22.81M | 19.73M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 36.55M | 35.56M | 10.93M | 930.00K | 3.69M | |||
| Accrued Expenses | 4.09M | 2.75M | 3.45M | 1.77M | 7.94M | |||
| Accounts Payable | 3.48M | 6.57M | 3.49M | 2.20M | 2.39M | |||
| Other Current Liabilities | 1.86M | 1.86M | 1.86M | 1.86M | 1.86M | |||
| Total Current Liabilities | 45.97M | 46.73M | 19.73M | 6.75M | 15.89M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 10.90M | 950.00K | |||
| Other Non-Current Liabilities | 59.56K | 6.22K | 60.00K | 550.00K | 70.00K | |||
| Total Non-Current Liabilities | 59.56K | 6.22K | 60.00K | 11.45M | 1.02M | |||
| TOTAL LIABILITIES | 46.03M | 46.74M | 19.79M | 18.20M | 16.91M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -479.10M | -467.92M | -408.94M | -342.88M | -289.72M | |||
| Additional Paid In Capital | 452.15M | 450.88M | 415.40M | 345.73M | 291.27M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 2.60M | 2.60M | 2.27M | 1.76M | 1.27M | |||
| Shares Outstanding | 13.01M | 260.26M | 227.31M | 176.46M | 127.18M | |||
| Tangible Book Value per Share | -1.87 | -0.06 | 0.04 | 0.03 | 0.02 | |||
| Total Shareholders' Equity | -24.34M | -14.44M | 8.74M | 4.61M | 2.83M | |||
| TOTAL LIABILITIES AND EQUITY | 21.68M | 32.30M | 28.53M | 22.81M | 19.73M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 2.36 | 0.34 | |||
| Current Ratio | 0.44 | 0.66 | 1.39 | 3.19 | 1.13 | |||
| Return On Assets (ROA) | -237.49% | -182.61% | -231.51% | -233.06% | -247.69% | |||
| Return On Equity (ROE) | N/A | N/A | -755.72% | -1153.15% | -1726.86% | |||
All data in USD